Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis

Immunology

Volumn 130, Issue 2, 2010, Pages 288-295

  Rzemieniak, Sarah E ^a   Hirschfeld, Aaron F ^a   Victor, Rachel E ^a   Chilvers, Mark A ^a   Zheng, Dongjun ^a   Van Den Elzen, Peter ^a   Turvey, Stuart E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acidification; Cystic fibrosis; Natural killer T cell; Pseudomonas aeruginosa

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIGEN; CD1D ANTIGEN; GALACTOSE GALACTOSYLCERAMIDE; GLYCOLIPID ANTIGEN; MESSENGER RNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; THIAZOLE DERIVATIVE; THIAZOLIDINONE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ACIDIFICATION; ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CELL VACUOLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYSOSOME; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD1D; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DENDRITIC CELLS; DRUG RESISTANCE, BACTERIAL; ENDOSOMES; FEMALE; GALACTOSYLCERAMIDES; HUMANS; LYMPHOCYTE ACTIVATION; MALE; NATURAL KILLER T-CELLS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; THIAZOLIDINEDIONES;

EID: 77952043094     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03234.x     Document Type: Article

References (39)

1. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006 173 : 475 482.
2. Ratjen F, Doring G. Cystic fibrosis. Lancet 2003 361 : 681 689. (Pubitemid 36246556)
3. Davies JC, Alton EW, Bush A. Cystic fibrosis. BMJ 2007 335 : 1255 1259.
4. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003 168 : 918 951. (Pubitemid 37267172)
5. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 2007 5 : 405 417. (Pubitemid 46780078)
6. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 2008 20 : 358 368.
7. Nieuwenhuis EE, Matsumoto T, Exley M et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002 8 : 588 593. (Pubitemid 34633436)
8. Nieuwenhuis EE, Matsumoto T, Lindenbergh D et al. Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest 2009 119 : 1241 1250.
9. Spada FM, Borriello F, Sugita M, Watts GF, Koezuka Y, Porcelli SA. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol 2000 30 : 3468 3477. (Pubitemid 32007060)
10. Mattner J, Debord KL, Ismail N et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005 434 : 525 529. (Pubitemid 40477062)
11. Kinjo Y, Wu D, Kim G et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005 434 : 520 525. (Pubitemid 40477061)
12. Christiansen D, Milland J, Mouhtouris E, Vaughan H, Pellicci DG, McConville MJ, Godfrey DI, Sandrin MS. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol 2008 6 : e172.
13. Briken V, Moody DB, Porcelli SA. Diversification of CD1 proteins: sampling the lipid content of different cellular compartments. Semin Immunol 2000 12 : 517 525. (Pubitemid 32055748)
14. Speak AO, Cerundolo V, Platt FM. CD1d presentation of glycolipids. Immunol Cell Biol 2008 86 : 588 597.
15. Prigozy TI, Naidenko O, Qasba P et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001 291 : 664 667. (Pubitemid 32150427)
16. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997 278 : 1626 1629. (Pubitemid 27516282)
17. Motohashi S, Nakayama T. Clinical applications of natural killer T cell-based immunotherapy for cancer. Cancer Sci 2008 99 : 638 645. (Pubitemid 351448064)
18. Silk JD, Salio M, Brown J, Jones EY, Cerundolo V. Structural and functional aspects of lipid binding by CD1 molecules. Annu Rev Cell Dev Biol 2008 24 : 369 395.
19. Finlay BB, Hancock RE. Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol 2004 2 : 497 504.
20. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature 1991 352 : 70 3. (Pubitemid 21896700)
21. Di A, Brown ME, Deriy LV et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 2006 8 : 933 944. (Pubitemid 44314724)
22. Teichgraber V, Ulrich M, Endlich N et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008 14 : 382 391. (Pubitemid 351499396)
23. Gottlieb RA, Dosanjh A. Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis. Proc Natl Acad Sci USA 1996 93 : 3587 3591. (Pubitemid 26125664)
24. Gibson GA, Hill WG, Weisz OA. Evidence against the acidification hypothesis in cystic fibrosis. Am J Physiol Cell Physiol 2000 279 : C1088 99.
25. Haggie PM, Verkman AS. Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages. J Biol Chem 2007 282 : 31422 31428. (Pubitemid 350044877)
26. Lukacs GL, Chang XB, Kartner N, Rotstein OD, Riordan JR, Grinstein S. The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH. J Biol Chem 1992 267 : 14568 14572.
27. Seksek O, Biwersi J, Verkman AS. Evidence against defective trans-Golgi acidification in cystic fibrosis. J Biol Chem 1996 271 : 15542 15548. (Pubitemid 26225328)
28. Barriere H, Bagdany M, Bossard F, Okiyoneda T, Wojewodka G, Gruenert D, Radzioch D, Lukacs GL. Revisiting the role of cystic fibrosis transmembrane conductance regulator and counter-ion permeability in the pH regulation of endocytic organelles. Mol Biol Cell 2009 20 : 3125 3141.
29. Haggie PM, Verkman AS. Unimpaired lysosomal acidification in respiratory epithelial cells in cystic fibrosis. J Biol Chem 2009 284 : 7681 7686.
30. Hirschfeld AF, Bettinger JA, Victor RE et al. Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin Immunol 2007 122 : 271 278.
31. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003 4 : 1230 1237. (Pubitemid 37540692)
32. Yu KO, Im JS, Molano A et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci USA 2005 102 : 3383 3388. (Pubitemid 40328054)
33. +)-ATPases - nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002 3 : 94 103. (Pubitemid 37237147)
34. Huss M, Wieczorek H. Inhibitors of V-ATPases: old and new players. J Exp Biol 2009 212 : 341 346.
35. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002 110 : 1651 1658. (Pubitemid 35424243)
36. Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis. Thorax 2007 62 : 360 367. (Pubitemid 46580580)
37. Yoshimura K, Nakamura H, Trapnell BC, Chu CS, Dalemans W, Pavirani A, Lecocq JP, Crystal RG. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res 1991 19 : 5417 5423. (Pubitemid 21912942)
38. Xu Y, Tertilt C, Krause A, Quadri LE, Crystal RG, Worgall S. Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells. Respir Res 2009 10 : 26.
39. Haggie PM, Verkman AS. Defective organellar acidification as a cause of cystic fibrosis lung disease: reexamination of a recurring hypothesis. Am J Physiol Lung Cell Mol Physiol 2009 296 : L859 67.